Evaluation of Ocular Findings in Pediatric Patients With Neurofibromatosis Type 1

Ulku Demir1

  • 1Department of Ophthalmology, Inonu University Faculty of Medicine, Malatya, Turkey.

PubMed

Insights

Neurofibromatosis type 1 (NF1) in children commonly causes ocular issues, with Lisch nodules showing significant age and gender variability. Comprehensive eye exams are vital for early NF1 diagnosis and vision preservation.

Area of Science:

  • Ophthalmology
  • Genetics
  • Pediatrics

Background:

  • Neurofibromatosis type 1 (NF1) is a genetic disorder with diverse clinical manifestations.
  • Ocular abnormalities are frequent in children with NF1, impacting visual health.
  • Understanding the incidence and variability of these manifestations is crucial for patient management.

Purpose of the Study:

  • To evaluate the incidence and variability of ocular manifestations in pediatric patients with NF1.
  • To analyze refractive errors, amblyopia, and other eye conditions in relation to age and gender.
  • To identify key ocular findings that require monitoring in children with NF1.

Main Methods:

  • Retrospective analysis of medical records of 71 children (aged 0-18 years) diagnosed with NF1.
  • Categorization of patients into age groups: 0-6, 7-12, and 13-18 years.
  • Ophthalmologic examinations included cycloplegic refraction, anisometropia, amblyopia assessment, and Lisch nodule evaluation.

Main Results:

  • No significant differences were found in the incidence of myopia, hypermetropia, astigmatism, anisometropia, amblyopia, optic glioma, strabismus, or ptosis based on age and gender.
  • A statistically significant difference was observed in the presence of iris Lisch nodules concerning age and gender (P < .05).
  • Ocular findings were common among the 71 evaluated pediatric NF1 patients.

Conclusions:

  • Pediatric patients with NF1 frequently exhibit ocular manifestations.
  • Comprehensive ophthalmologic examinations are essential for early detection and management of NF1-related eye conditions.
  • Timely diagnosis and treatment are critical for improving the clinical course and preserving vision in children with NF1.